The treatment method of Jaypirca by Eli Lilly for the treatment of lymphocytic leukemia has been approved by the FDA 2023-12-03 17:07 / Leave a Comment December 2nd, Eli Lilly announced that their therapy Jaypirca (Pirtobrutinib/Pirtotinib) for the treatment of lymphocytic leukemia has been approved by the U.S. Food and Drug Administration (FDA).